Showing results 1 to 5 of 5
Title | Author(s) | Issue Date | |
---|---|---|---|
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2 Journal:Nature Communications | 2021 | ||
Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model Journal:Nature Communications | 2022 | ||
Distinct disease severity between children and older adults with COVID-19: Impacts of ACE2 expression, distribution, and lung progenitor cells Journal:Clinical Infectious Diseases | 2021 | ||
Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants Journal:Emerging Microbes & Infections | 2022 | ||
Integrated analysis of mRNA-seq and miRNA-seq for host susceptibilities to influenza A (H7N9) infection in inbred mouse lines Journal:Functional & Integrative Genomics | 2018 |